Increased
0.12% → 0.16%(+0.03 pp)
Bridgewater Associates added 20,975 shares; portfolio weight moved from 0.12% to 0.16%.
+20,975 Shares
+24.50%
Back to 13F data
Unclassified
ALNYLAM PHARMACEUTICALS INC
Original CUSIPs: 02043Q107. This page shows current managers, quarterly changes, and primary SEC sources.
Current managers
1
Latest reporting quarter
Q1 2026
Who holds it and what changed this quarter
Portfolio weight and share-count changes are shown for every tracked manager with a current or prior-quarter position.
SEC05/15/2026
Four-quarter trend
Each line is one tracked manager’s portfolio weight. Labels identify the manager directly.
Historical and source details
Market values, quarterly totals, and original CUSIP rows are available below without obscuring current actions.
Quarterly holdings details
| Quarter | Current managers | Combined value | Total shares | Manager details |
|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0 | |
| Q3 2025 | 1 | $15,463,416 | 33,911 | Bridgewater Associates New position |
| Q4 2025 | 1 | $34,045,600 | 85,617 | Bridgewater Associates Increased |
| Q1 2026 | 1 | $35,268,095 | 106,592 | Bridgewater Associates Increased |
Original CUSIP details
| Manager | Issuer | CUSIP | Security class | Market value | Shares | Weight | Source |
|---|---|---|---|---|---|---|---|
| Bridgewater Associates | ALNYLAM PHARMACEUTICALS INC | 02043Q107 | COM | $35,268,095 | 106,592 | 0.16% | SEC XML |
Data source
Holdings facts come from SEC 13F information tables. Tickers, company aliases, and themes are used only for search and normalized display, not as a holdings source.